Skip to content

Clinical trials

Completed Phase 2/3 Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20072
20091
20121
20163
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Bellus Health Inc. - a GSK company1
Bristol-Myers Squibb1
Celgene Corporation1
Federation Francophone de Cancerologie Digestive1
GUO WEI1
Hotel Dieu de France Hospital1
Novartis Pharmaceuticals1
Odense University Hospital1
Oncoscience AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis14
Colorectal Neoplasms2
Amyloidosis1
Arthritis, Rheumatoid1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Familial Mediterranean Fever1
Gastrointestinal Diseases1
Head and Neck Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.